JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 15, 2005; DOI: 10.1124/jpet.105.084954


0022-3565/05/3141-455-466$20.00
JPET 314:455-466, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.084954v1
314/1/455    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuo, Y.-P.
Right arrow Articles by Lukas, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuo, Y.-P.
Right arrow Articles by Lukas, R. J.

NEUROPHARMACOLOGY

Roles for Nicotinic Acetylcholine Receptor Subunit Large Cytoplasmic Loop Sequences in Receptor Expression and Function

Yen-Ping Kuo, Lin Xu, J. Brek Eaton, Lingke Zhao, Jie Wu, and Ronald J. Lukas

Division of Neurobiology (Y.-P.K., L.X., J.B.E., R.J.L.) and Neurology (L.Z., J.W.), Barrow Neurological Institute, Phoenix, Arizona

To evaluate possible physiological roles of the large cytoplasmic loops (C2) and neighboring transmembrane domains of nicotinic acetylcholine receptor (nAChR) subunits, we generated novel fusion constructs in which human nAChR {alpha}4, {beta}2, or {beta}4 subunit C2 or C2 and neighboring sequences were replaced by corresponding sequences from the mouse serotonin type 3A (5-HT3A) receptor subunit. Following stable expression in human SH-EP1 cells, we found that extensive sequence substitutions involving third and fourth transmembrane domains and neighboring "proximal" C2 sequences (e.g., {beta}2 H322-V335 and V449-R460) did not allow functional expression of nAChR containing chimeric subunits. However, expression of functional nAChR was achieved containing wild-type {alpha}4 subunits and chimeric {beta}2 ({beta}2{chi}) subunits whose "nested" C2 domain sequences K336-S448 were replaced with the corresponding 5-HT3A subunit sequences. Whereas these findings suggested indispensable roles for M3/M4 transmembrane and/or proximal C2 sequences in {alpha}4{beta}2-nAChR function, nested C2 sequences in the {beta}2 subunit are not essential for functional receptor expression. Ligand-binding analyses also revealed only subtle differences in pharmacological profiles of {alpha}4{beta}2-nAChR compared with {alpha}4{beta}2{chi}-nAChR. Nevertheless, there was heightened emergence of agonist-mediated self-inhibition of {alpha}4{beta}2{chi} function, greater sensitivity to functional blockade by a number of antagonists, and faster and more complete acute desensitization of {alpha}4{beta}2{chi}-nAChR than for {alpha}4{beta}2-nAChR. These studies are consistent with unexpected roles of nested C2 sequences in nAChR function.


Received February 16, 2005; accepted April 13, 2005.

Address correspondence to: Dr. Yen-Ping Kuo, Department of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013. E-mail: ykuo{at}chw.edu.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. E. Carland, M. A. Cooper, S. Sugiharto, H.-J. Jeong, T. M. Lewis, P. H. Barry, J. A. Peters, J. J. Lambert, and A. J. Moorhouse
Characterization of the Effects of Charged Residues in the Intracellular Loop on Ion Permeation in {alpha}1 Glycine Receptor Channels
J. Biol. Chem., January 23, 2009; 284(4): 2023 - 2030.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. X. Albuquerque, E. F. R. Pereira, M. Alkondon, and S. W. Rogers
Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
Physiol Rev, January 1, 2009; 89(1): 73 - 120.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Zwart, A. L. Carbone, M. Moroni, I. Bermudez, A. J. Mogg, E. A. Folly, L. M. Broad, A. C. Williams, D. Zhang, C. Ding, et al.
Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant {alpha}4{beta}2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., June 1, 2008; 73(6): 1838 - 1843.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Wu, Q. Liu, K. Yu, J. Hu, Y.-P. Kuo, M. Segerberg, P. A. St John, and R. J. Lukas
Roles of nicotinic acetylcholine receptor {beta} subunits in function of human {alpha}4-containing nicotinic receptors
J. Physiol., October 1, 2006; 576(1): 103 - 118.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. A. Briggs, E. J. Gubbins, M. J. Marks, C. B. Putman, R. Thimmapaya, M. D. Meyer, and C. S. Surowy
Untranslated Region-Dependent Exclusive Expression of High-Sensitivity Subforms of {alpha}4beta2 and {alpha}3beta2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., July 1, 2006; 70(1): 227 - 240.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.